Harvard Bioscience Announces First Quarter 2022 Financial Results
May 04, 2022 07:00 ET
|
Harvard Bioscience, Inc.
•Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwinds HOLLISTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:...
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
April 26, 2022 09:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) has introduced SmartStudy™, an innovative technology feature to its Buxco® Inhalation System aimed at...
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
April 21, 2022 16:05 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May...
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
March 08, 2022 07:00 ET
|
Harvard Bioscience, Inc.
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwindsGross margin improves to 59% in Q4 driven by strengthening product mix, improved operating leverage ...
Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET
February 21, 2022 16:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on...
Harvard Bioscience Announces Third Quarter 2021 Financial Results
November 03, 2021 07:00 ET
|
Harvard Bioscience, Inc.
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 23% year-over-year as sales momentum continuesPre-clinical product revenue up...
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
October 18, 2021 16:50 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on...
Harvard Bioscience Announces Second Quarter 2021 Financial Results
August 05, 2021 07:00 ET
|
Harvard Bioscience, Inc.
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 25% year-over-year as sales momentum continuesCellular and Molecular (CMT) product...
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
July 19, 2021 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on...
Harvard Bioscience Announces First Quarter 2021 Financial Results
May 06, 2021 07:15 ET
|
Harvard Bioscience, Inc.
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins Revenue up 14% as sales momentum from Q4’20 continuesPre-clinical product...